Pelthos Therapeutics, Inc. (PTHS)
23.94
-1.09
(-4.35%)
USD |
NYAM |
Dec 11, 16:00
24.00
+0.06
(+0.25%)
After-Hours: 20:00
Pelthos Therapeutics Shareholders Equity (Quarterly): 58.25M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | 950.17M |
| Agenus, Inc. | -274.14M |
| Protalix Biotherapeutics, Inc. | 52.91M |
| Travere Therapeutics, Inc. | 73.56M |
| Genprex, Inc. | 0.7678M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.43M |
| Total Liabilities (Quarterly) | 68.18M |
| Debt to Equity Ratio | 0.0597 |
| Current Ratio | 1.980 |
| Net Debt Paydown Yield | -3.77% |